ALERT: Rowley Law PLLC Is Investigating Proposed Acquisition of Pieris Pharmaceuticals, Inc.
ALERT: Rowley Law PLLC Is Investigating Proposed Acquisition of Pieris Pharmaceuticals, Inc.
NEW YORK, July 24, 2024 /PRNewswire/ -- Rowley Law PLLC is investigating potential securities law violations by Pieris Pharmaceuticals, Inc. (NASDAQ: PIRS) and its board of directors concerning the proposed acquisition of the company by Palvella Therapeutics, Inc. Pieris Pharmaceuticals stockholders are expected to own approximately 18% of the combined company. The transaction is expected to close in the fourth quarter of 2024.
羅利律師事務所正在調查Pieris Pharmaceuticals, Inc.（納斯達克:PIRS）及其董事會因被Palvella Therapeutics, Inc. 收購提議涉嫌潛在證券法違規問題。Pieris Pharmaceuticals股東預計將持有合併後公司的約18％。交易預計將於2024年第四季度關閉。
If you are a stockholder of Pieris Pharmaceuticals, Inc. and are interested in obtaining additional information regarding this investigation, please visit us at: /. You may also contact Shane Rowley, Esq. at Rowley Law PLLC, 50 Main Street Suite 1000, White Plains, NY 10606, by email at [email protected], or by telephone at 914-400-1920 or 844-400-4643 (toll-free).
如果您是Pieris Pharmaceuticals，Inc.的股東，並且有興趣獲取有關此調查的其他信息，請訪問我們：/。您也可以通過電子郵件與Shane Rowley律師聯繫，地址爲：紐約州懷特普萊恩斯市50 Main Street Suite 1000。[email protected]。
Rowley Law PLLC represents shareholders nationwide in class actions and derivative lawsuits in complex corporate litigation. For more information about the firm and its attorneys, please visit .
Rowley Law PLLC代表全國股東參與複雜企業訴訟中的集體訴訟和衍生訴訟。有關該公司及其律師的更多信息，請訪問 .
Attorney Advertising. Prior results do not guarantee a similar outcome.
律師廣告。之前的結果不能保證類似的結果。
SOURCE Rowley Law PLLC
消息來源：Rowley Law PLLC
譯文內容由第三人軟體翻譯。